Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
10.10.2013 14:00:00

Upcoming Earnings Schedules, Acquisitions, Partnerships, and Unrestricted Grants for Community Programs - Research Report on Intuitive Surgical, Abbott, MAKO Surgical, Allscripts, and ABIOMED

New York, October 10, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Intuitive Surgical, Inc. (NASDAQ: ISRG), Abbott Laboratories (NYSE: ABT), MAKO Surgical Corp. (NASDAQ: MAKO), Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX), and ABIOMED, Inc. (NASDAQ: ABMD). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Intuitive Surgical, Inc. Research Report

On September 25, 2013, Intuitive Surgical, Inc. (Intuitive Surgical) announced that it will host its Q3 2013 conference call on Thursday, October 17, 2013 at 4:30 p.m. ET. Intuitive Surgical informed that the call will be webcast by Thomson Reuters, and will be accessible through the Company's website. The Full Research Report on Intuitive Surgical, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/5f98_ISRG]

--

Abbott Laboratories Research Report

On September 25, 2013, Abbott Laboratories (Abbott) announced that it will release its Q3 2013 financial results before the market opens on Wednesday, October 16, 2013. Abbott reported that the results release will be followed by a live webcast of the quarterly earnings conference call at 8:00 a.m. CT (9:00 a.m. ET), and will be accessible through its Investor Relations website. The Company also informed that an archived edition of the call will be accessible after 11:00 a.m. CT. The Full Research Report on Abbott Laboratories - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/05c1_ABT]

--

MAKO Surgical Corp. Research Report

On October 2, 2013, MAKO Surgical Corp. (MAKO) announced that it has entered into an agreement with Pipeline Biomedical Holdings for the acquisition of substantially all of Pipeline's business dedicated to the design, development, manufacture, and commercialization of orthopedic devices and related instruments for use with both robotic devices and manual medical procedures. MAKO reported that the transaction purchase price consists of a credit for a cash down payment previously paid to Pipeline in the amount of $2.5 million and the issuance of an aggregate of approximately 4.0 million unregistered shares of common stock of MAKO. The Full Research Report on MAKO Surgical Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/7465_MAKO]

--

Allscripts Healthcare Solutions, Inc. Research Report

On October 2, 2013, Allscripts Healthcare Solutions, Inc. (Allscripts) reported that PIH Health, a healthcare system, has selected the Company's Sunrise product suite as the electronic health record (EHR) solution for its newly acquired 199-bed acute care facility, PIH Health Hospital - Downey (formerly Downey Regional Medical Center). Commenting on the product suite selection, Davis Lee, MD, Chief Medical Information Officer of PIH Health, stated, "Allscripts solutions are integrated, interoperable and innovative. Partnering with Allscripts helps us with the demands of the evolving regulatory, population health and accountable care requirements and also provides us with the tools to exceed our care standards and meet our business goals." Further, Paul M. Black, President and CEO of Allscripts commented, "Allscripts products and services can improve adoption, utilization and care coordination and deliver outcomes that enable our clients to deliver efficient and effective care. We are delighted that PIH Health has decided to extend and grow their relationship with Allscripts." The Full Research Report on Allscripts Healthcare Solutions, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/1787_MDRX]

--

ABIOMED, Inc. Research Report

On October 1, 2013, ABIOMED, Inc. (Abiomed) reported that it has donated an unrestricted grant in the amount of $375,000 to Boston Children's Hospital Heart Center, a newly dedicated cardiovascular care center founded within Boston Children's Hospital. Michael R. Minogue, Chairman, President, and CEO of Abiomed said, "We are very excited about this area of research for pediatric heart failure patients. Abiomed is pleased to support Boston Children's research and advancements for new, cutting edge technologies in the field of pediatric cardiac care." The Full Research Report on ABIOMED, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/ea34_ABMD]

----

EDITOR NOTES:

  • This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  • Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  • This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  • For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

  • COMPLIANCE PROCEDURE

    Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

    NOT FINANCIAL ADVICE

    Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

    NO WARRANTY OR LIABILITY ASSUMED

    Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

    CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

    AnalystsCorner.com

    SOURCE Analysts' Corner

    Nachrichten zu ABIOMED Inc.mehr Nachrichten

    Keine Nachrichten verfügbar.

    Analysen zu ABIOMED Inc.mehr Analysen

    Eintrag hinzufügen
    Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
    Es ist ein Fehler aufgetreten!

    Aktien in diesem Artikel

    Abbott Laboratories 112,12 0,27% Abbott Laboratories
    Allscripts Healthcare Solutions Inc 9,30 5,68% Allscripts Healthcare Solutions Inc
    Intuitive Surgical Inc 524,10 -0,15% Intuitive Surgical Inc